CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Duncan Charles Cliff Director | Purchase | +5,803 | $3.80 | $22K | 108,701 |
| 2026-11-04 | Duncan Charles Cliff Director | Purchase | +3,447 | $3.82 | $13K | 102,898 |
| 2026-11-03 | Duncan Charles Cliff Director | Purchase | +750 | $3.80 | $3K | 99,451 |
| 2026-06-04 | McGuire Daniel Patrick SVP, GC and Secretary | Grant or award | +80,000 | 109,982 | ||
| 2026-06-04 | Chrousos Phaedra Director | Grant or award | +41,600 | 164,950 | ||
| 2026-06-04 | Duncan Charles Cliff Director | Grant or award | +41,600 | 98,701 | ||
| 2026-06-04 | DUGAN RICHARD W Director | Grant or award | +41,600 | 219,054 | ||
| 2026-06-04 | Ward Anne Sempowski Director | Grant or award | +41,600 | 160,667 | ||
| 2026-06-04 | Honore Tage Director | Grant or award | +41,600 | 135,069 | ||
| 2026-06-04 | Mitchell Stephen Ray Director | Grant or award | +41,600 | 112,846 | ||
| 2026-05-18 | Mitchell Stephen Ray Director | Gift | −25,836 | 71,246 | ||
| 2026-04-22 | Duncan Charles Cliff Director | Grant or award | +57,101 | 57,101 | ||
| 2026-03-02 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −42,442 | $8.27 | $351K | 411,380 |
| 2026-03-02 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −30,800 | $8.27 | $255K | 333,469 |
| 2026-03-02 | Williams Timothy SVP & General Counsel | Sale | −42,434 | $8.27 | $351K | 377,450 |
| 2026-03-02 | Birznieks Gunther SVP, Business Development | Sale | −42,431 | $8.27 | $351K | 494,197 |
| 2026-03-02 | Polymeropoulos Mihael Hristos President and CEO | Sale | −156,235 | $8.17 | $1.3M | 2,704,496 |
| 2026-02-23 | Honore Tage Director | Sale | −30,000 | $8.03 | $241K | 93,469 |
| 2026-02-18 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award | +125,000 | 364,269 | ||
| 2026-02-18 | Birznieks Gunther SVP, Business Development | Grant or award | +125,000 | 536,628 |
Page 1 of 8 · 153 trades